CDC panel authorizes COVID-19 vaccine boosters for high-risk people, those over 65
Story Date: 9/24/2021

 

Source: Nathaniel Weixel, THE HILL, 9/23/21


A Centers for Disease Control and Prevention (CDC) advisory panel on Thursday recommended booster doses of the Pfizer-BioNTech coronavirus vaccine for people at least 65 years old, paving the way for boosters in a large swatch of the American population. The CDC Advisory Committee on Immunization Practices (ACIP) voted 15-0 to recommend a booster dose for Americans age 65 and older and people in long term care facilities.

For more of this story, click here

























   Copyright © 2007 North Carolina Agribusiness Council, Inc. All Rights Reserved.
   All use of this Website is subject to our
Terms of Use Agreement and our Privacy Policy.